M5G-29340-54054
4 vaccinations
2 coded responses
25 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 212 / MD
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Registered dependents
HW8-38630-93619
Child or adolescent in my care · Female · 2022-07-02
8TS-59938-33510
Child or adolescent in my care · Female · 2022-07-02
RSA-20367-04064
Child or adolescent in my care · Female · 2022-07-02
Timeline
-
2021-03-22
Registered in v-safe
-
2021-03-22
Dose 1 — Pfizer-BioNTech
-
2021-03-22
Survey response — day 0, dose 1MedDRA: Breast tenderness — Feeling: Fair · Fatigue or tirednessFree text: Breast tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-25
- 2021-03-26
- 2021-03-31
- 2021-04-05
-
2021-04-12
Dose 2 — Pfizer-BioNTech
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-11
- 2021-05-17
- 2021-05-24
- 2021-07-12
-
2021-10-11
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2021-10-11
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-29
-
2021-11-20
Dose 3 — Pfizer-BioNTech
- 2022-04-12
-
2022-09-15
Dose 4 — Pfizer-BioNTech
- 2022-10-03
- 2022-10-09
- 2022-10-13
- 2022-10-20
- 2022-12-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Pfizer-BioNTech | |
| 2 | 2021-04-12 | Pfizer-BioNTech | |
| 3 | 2021-11-20 | Pfizer-BioNTech | No |
| 4 | 2022-09-15 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): Breast tenderness
Release 10 — 6 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
| SRO | Breast tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release